Praxis Precision Medicines
Price & Volume
Stats
See moreOpen | $327.50 |
Previous Close | $317 |
Day Range | $326.67-$353.33 |
52W Range | $28.79-$356 |
Market Cap | $8.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $7.4M |
Revenue Growth (YoY) | 1,349.1% |
Gross Profit (12 Mos) | -$267.1M |
Diluted EPS | -$13.47 |
News
See moreYahoo Finance • 9 hours ago
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
Yahoo Finance • 20 days ago
Sarepta (SRPT) Skyrockets 35% on Morgan Stanley PT Hike, Stellar Trial Results
Yahoo Finance • 23 days ago
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
Yahoo Finance • 29 days ago
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
About
CEO | Mr. Marcio Silva De'Souza M.B.A. |
CFO | Mr. Timothy Edwin Kelly |
Address | 99 High Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 168 |
